Your search returned 34 studies. (Get alerts for new studies):
- A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Conditions: Metastatic Breast Cancer - Advanced Breast Cancer - Gastrointestinal Stromal Tumor - Hepatocellular Carcinoma - Metastasizing Breast Cancer (F) - Metastatic Castration-Resistant Prostrate Cancer - Metastatic Renal Cell Cancer - Non Small Cell Lung Cancer
2 Locations available
- A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Pri
Conditions: Metastatic Renal Cell Carcinoma
5 Locations available
- BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)
Conditions: Renal Cell Carcinoma
1 Location available
- Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
Conditions: Advanced Adult Hepatocellular Carcinoma
1 Location available
- A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic Cancer
Conditions: Advanced Adenocarcinoma - Metastatic Adenocarcinoma
1 Location available
- Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma
Conditions: Biliary Cancer - Cholangiocarcinoma
1 Location available
- Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
Conditions: Hepatocellular Carcinoma
1 Location available
- Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer
Conditions: Renal Cell Carcinoma - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer
1 Location available
- Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma
Conditions: Advanced Non-clear Cell Renal Cell Carcinoma
9 Locations available
- Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Conditions: Adenocarcinoma - Her2+ - Advanced Metastatic Breast Cancer - Metastatic ErbB2 - Invasive Breast Cancer - Advanced Breast Cancer - Cancer - ErbB2+
19 Locations available
- A Study of RO5137382 (GC33) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
Conditions: Liver Cancer
1 Location available
- Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer
Conditions: Advanced Metastatic Carcinoma
1 Location available
- A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma
Conditions: Metastatic Pancreatic Adenocarcinoma
2 Locations available
- A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum
Conditions: Non-Metastatic Adenocarcinoma of the Rectum
1 Location available
- Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma
Conditions: Head and Neck Cancer
1 Location available
- IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma
Conditions: Metastatic Renal Cell Carcinoma
18 Locations available
- Study of MK-3475 in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475
Conditions: Cancer, Solid Tumor
13 Locations available
- Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors
Conditions: Basal Cell Carcinoma
1 Location available
- Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Conditions: Hereditary Clear Cell Renal Cell Carcinoma - Kidney Cancer
1 Location available
- A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
Conditions: Basal Cell Carcinoma
24 Locations available
- Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma
Conditions: Bladder Cancer
1 Location available
- Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
Conditions: Non-small Cell Lung Cancer Metastatic - Small Cell Lung Carcinoma
5 Locations available
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
398 Locations available
- A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Recurrent or Refractory Medulloblastoma - Locally Advanced or Metastatic Basal Cell Carcinoma
2 Locations available
- A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
Conditions: Hedgehog Pathway - Smoothened - Basal Cell Carcinoma (BCC) - Basal Cell Nevoid Syndrome (BCNS)
2 Locations available
- A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies
Conditions: Metastatic Castration-resistant Prostrate Cancer (mCRPC) - Renal Cell Carcinoma (RCC) - Metastatic Melanoma (MEL) - Non-small Cell Lung Cancer (NSCLC)
10 Locations available
- GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Conditions: Adenocarcinoma of the Pancreas - Advanced Solid Tumors - Cancer - Cancer of Pancreas - Cancer of the Pancreas - Metastases - Metastatic Cancer - Metastatic Pancreatic Cancer - Pancreas Cancer - Pancreatic Cancer - Bone Metastases - Endocrine Cancer - Onco
20 Locations available
- TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors or Advanced Pancreatic Ca
Conditions: Adenocarcinoma of the Pancreas - Stage III Pancreatic Cancer - Stage IV Pancreatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma
Conditions: Cholangiocarcinoma - Liver Neoplasms
1 Location available
- Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-Naive Patients With Advanced/Metastatic Bladder Carcinoma
Conditions: Bladder Cancer
1 Location available
- MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
Conditions: Advanced Nonhematological Malignancies - Non-Small Cell Lung Cancer - Small Cell Lung Cancer - Metastatic Breast Cancer - Head and Neck Squamous Cell Carcinoma - Gastroesophageal Adenocarcinoma
3 Locations available
- Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Metastatic Breast Cancer - Metastatic Renal Cell Carcinoma
1 Location available
- Combination Chemotherapy in Treating Patients With Advanced or Metastatic Esophageal Cancer, Gastric Cancer, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
136 Locations available
|